TC-2153
TC-2153 Basic information
- Product Name:
- TC-2153
- Synonyms:
-
- benzopentathiepin 8-(trifluoromethyl)-1,2,3,4,5-benzopentathiepin-6-amine hydrochloride
- TC-2153
- TC-2153 >=95% (HPLC)
- TC-2153 hydrochloride
- CAS:
- 1381769-23-8
- MF:
- C7H5ClF3NS5
- MW:
- 355.87
- Mol File:
- 1381769-23-8.mol
TC-2153 Chemical Properties
- storage temp.
- -20°C
- solubility
- DMSO: 5mg/mL, clear
- form
- powder
- color
- white to beige
TC-2153 Usage And Synthesis
Uses
TC-2153 is a selective inhibitor of striatal-enriched protein tyrosine phosphatase (STEP), with psychotropic activity and low acute toxicity. TC-2153 increases the expression of brain-derived neurotropic factor (BDNF) in the brain. And it decreases MAOA and 5-HT1A receptors mRNA level in midbrain. TC-2153 also inhibits 5-HT2A receptor-mediated signaling[1].
Biochem/physiol Actions
TC-2153 is a potent inhibitor of STEP (STriatal-Enriched protein tyrosine Phosphatase) that forms a reversible covalent bond with the catalytic cysteine in STEP. TC-2153 increases tyrosine phosphorylation of STEP substrates ERK1/2, Pyk2, and GluN2B in cell cultures. TC-2153 improves cognitive function in transgenic AD mice.
in vivo
Chronic TC-2153 treatment: TC-2153 (20 mg/kg; i.p.; once daily for 7 d) shows antidepressant-like effect without altering locomotor, exploratory activity and anxiety[1].
Acute TC-2153 treatment: TC-2153 (10 mg/kg and 20 mg/kg; p.o.; single dose) inhibits the functional activity of 5-HT2A receptors in vivo in mice[1].
| Animal Model: | SPF-state adult mouse males[1] |
| Dosage: | 10 mg/kg and 20 mg/kg; with or without 1 mg/kg DOI i.p. at 3 h after final treatment |
| Administration: | Oral gavage or intraperitoneal injection; single dose or once daily for 7 d |
| Result: | Showed antidepressant-like effect in the forced swim test without any adverse side effects on locomotor activity, anxiety, exploration, motor skill and obsessive-compulsive-like behavior. Both acute and chronic methods inhibited the functional activity of 5-HT2A receptors. |
IC 50
5-HT1A Receptor; 5-HT2A Receptor; MAO-A
References
[1] Walters JM, et al. Pharmacological inhibition of STriatal-Enriched protein tyrosine Phosphatase by TC-2153 reduces hippocampal excitability and seizure propensity. Epilepsia. 2022 May;63(5):1211-1224. DOI:10.1111/epi.17192
TC-2153Supplier
- Tel
- 021-61415566 800-8193336
- orderCN@merckgroup.com
- Tel
- +86-400-002-6226 +86-13028896684;
- sales@rrkchem.com
- Tel
- 021-58447131 13564518121
- doncunbiosci@gmail.com
- Tel
- 021-58432009 400-005-6266
- marketing1@energy-chemical.com
- Tel
- 4008200310
- marketing@tsbiochem.com